Tri-Pase-8 8000 UNT / 30,000 UNT / 30,000 UNT Oral Tablet
RxNorm 1089866
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1089866 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tri-Pase-8 8000 UNT / 30,000 UNT / 30,000 UNT Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 30000 UNT / lipase 8000 UNT / protease 30000 UNT Oral Tablet [Tri-Pase]
(Atom ID: 12367572)
SY
Synonym (SY):
Tri-Pase (amylase 30,000 UNT / protease 30,000 UNT / lipase 8000 UNT) Oral Tablet
(Atom ID: 11845886)
SY
Synonym (SY):
Tri-Pase (amylases 30,000 UNT / endopeptidases 30,000 UNT / lipase 8000 UNT) Oral Tablet
(Atom ID: 11845885)
PSN